COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

31,780 Articles (22,946 medRxiv, 8,834 bioRxiv)

Most recent first Previous |  Page 2802: Articles 28011-28020  | Next

Performance of progressive and adaptive COVID-19 exit strategies: a stress test analysis for managing intensive care unit rates
van Wees, J.-D., van der Kuip, M., Osinga, S., van Westerloo, D., Tanck, M., Hanegraaf, M., Pluymaekers, M., Leeuwenburgh, O., van Bijsterveldt, L., Verreijdt, P., Brunner, L., Tutu van Furth, M.
10.1101/2020.05.16.20102947 — Posted: 2020-05-20
Estimating the cost-of-illness associated with the COVID-19 outbreak in China from January to March 2020
Jin, H., Wang, H., Li, X., Zheng, W., Ye, S., Zhang, S., Zhou, J., Pennington, M.
10.1101/2020.05.15.20102863 — Posted: 2020-05-20
Quantifying antibody kinetics and RNA shedding during early-phase SARS-CoV-2 infection
Borremans, B., Gamble, A., Prager, K. C., Helman, S. K., McClain, A. M., Cox, C., Savage, V., Lloyd-Smith, J. O.
10.1101/2020.05.15.20103275 — Posted: 2020-05-20 Discussion: Onsite
Access to primary healthcare during lockdown measures for COVID-19 in rural South Africa: a longitudinal cohort study
Siedner, M. J., Kraemer, J. D., Meyer, M. J., Harling, G., Mngomezulu, T., Gabela, P., Dlamini, S., Gareta, D., Majozi, N., Ngwenya, N., Reynolds, Z., Seeley, J., Wong, E., Iwuji, C., Shahmanesh, M., Hanekom, W., Herbst, K.
10.1101/2020.05.15.20103226 — Posted: 2020-05-20 Discussion: Onsite
Trust, threats, and consequences of the COVID-19 pandemic in Norway and Sweden: A comparative survey
Helsingen, L. M., Refsum, E., Gjostein, D. K., Loberg, M., Bretthauer, M., Kalager, M., Emilsson, L.
10.1101/2020.05.16.20089953 — Posted: 2020-05-20
Metamorphosis of COVID-19 Pandemic
Saif, F.
10.1101/2020.05.17.20073189 — Posted: 2020-05-20
COVID-19 death rates by age and sex and the resulting mortality vulnerability of countries and regions in the world
Guilmoto, C. Z. Z.
10.1101/2020.05.17.20097410 — Posted: 2020-05-20
Assessment of dispersion of airborne particles of oral/nasal fluid by high flow nasal cannula therapy
Jermy, M. C., Spence, C. J., Kirton, R., O'Donnell, J. F., Kabaliuk, N., Gaw, S., Jiang, Y., Zainol Abidin, Z., Dougherty, R. L., Rowe, P., Mahaliyana, A., Gibbs, A., Roberts, S.
10.1101/2020.05.14.20102517 — Posted: 2020-05-20
Preventive behavior of Vietnamese people in response to the COVID-19 pandemic
Thang, T. V., Nguyen, N. P. T., Hoang, T. D., Tran, V. T., Vu, C. T., Nelson Siewe, J., Colebunders, R., Dunne, M.
10.1101/2020.05.14.20102418 — Posted: 2020-05-20
Feasibility of Reusing Surgical Mask Under Different Disinfection Treatments
SUEN, C. Y., LEUNG, H. H., LAM, K. W., HUNG, K. P., CHAN, M. Y., KWAN, J. K. C.
10.1101/2020.05.16.20102178 — Posted: 2020-05-20

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).